Related Experiment Video

Updated: Jul 16, 2026

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

Nasal lavage leukotrienes in infants with RSV bronchiolitis

Liviana Da Dalt1, Silvia Callegaro, Silvia Carraro

  • 1Department of Pediatrics, University of Padova, Padova, Italy. dadalt@pediatria.unipd.it

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|March 7, 2007
PubMed

Insights

Infants with respiratory syncytial virus (RSV) bronchiolitis have higher levels of cysteinyl leukotrienes (Cys-LTs) in nasal fluid. These elevated Cys-LT levels persist for at least one month post-infection, suggesting a role in infant lung damage.

Area of Science:

  • Pediatrics
  • Immunology
  • Respiratory Medicine

Background:

  • Respiratory syncytial virus (RSV) bronchiolitis is a common infant infection.
  • Persistent reactive airway disease can follow acute RSV bronchiolitis.
  • The role of leukotrienes in RSV-induced lung damage is under investigation.

Purpose of the Study:

  • To measure leukotriene levels in infants during and after RSV bronchiolitis.
  • To investigate the potential role of leukotrienes in the pathogenesis of RSV bronchiolitis sequelae.

Main Methods:

  • Collected nasal lavage fluid (NLF) from infants with RSV bronchiolitis and healthy controls.
  • Measured cysteinyl leukotrienes (Cys-LTs) and leukotriene B4 (LTB4) in NLF.
  • Collected a second NLF sample one month after acute infection for follow-up measurements.

Main Results:

  • Significantly higher NLF Cys-LT levels were found in infants with RSV bronchiolitis compared to controls.
  • Elevated Cys-LT levels persisted one month after the acute RSV infection.
  • No significant differences in LTB4 levels were observed between groups.

Conclusions:

  • Cys-LTs are significantly increased in infants with acute RSV bronchiolitis.
  • Sustained elevation of Cys-LTs suggests a potential role in the long-term lung damage following RSV bronchiolitis.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...